Ligand Pharmaceuticals Incorporated

The annual 10-K, the quarterly 10-Q and the 8-K filed between them when something material happens.

1. Sep 248-KRegulation FD disclosure and other events7.018.01
2. Sep 228-KRegulation FD disclosure7.019.01
3. Sep 28-K/AFinancial statements and exhibits (amended)9.01
4. Aug 1313GPassive stake of 5% or more (13G), filed by Invesco
5. Aug 710-QQuarterly report
6. Aug 68-KResults of operations2.029.01
7. Jul 148-KMaterial agreement and acquisition or sale of assets completed1.012.012.037.019.01
8. Jun 258-KMaterial agreement and unregistered sale of shares1.012.033.028.019.01
9. Jun 228-KMaterial agreement and other events1.018.019.01
10. Jun 98-KOfficer or director change and shareholder vote5.025.07
11. May 188-KMaterial agreement1.019.01
12. May 810-QQuarterly report
13. May 78-KResults of operations2.029.01
14. Apr 308-KEnd of a material agreement1.02
15. Apr 278-KMaterial agreement and other events1.018.01
16. Feb 2710-KAnnual report
17. Feb 268-KResults of operations2.029.01
18. Dec 18, 20258-KRegulation FD disclosure7.01
19. Nov 7, 202510-QQuarterly report
20. Nov 6, 20258-KResults of operations2.029.01
21. Sep 16, 20258-KMaterial agreement and new debt or obligation1.012.039.01
22. Aug 14, 20258-KMaterial agreement and unregistered sale of shares1.012.033.028.019.01
23. Aug 11, 20258-KMaterial agreement and other events1.018.019.01
24. Aug 8, 202510-QQuarterly report
25. Aug 7, 20258-KResults of operations2.029.01
26. Jul 2, 20258-KRegulation FD disclosure7.019.01